NASDAQ:LEXX

Lexaria Bioscience Corp’s latest rating changes from various analysts
Anna Perez
Lexaria Bioscience Corp’s recent filing unveils that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ...

Lexaria Bioscience Corp’s recent filing unveils that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ...